New research advances and future prospect in precision treatment of triple-negative breast cancer
According to the latest data released by the Cancer Research Institute of the World Health Organization, breast cancer has replaced lung cancer as the malignant tumor with the highest incidence rate in the world. Triple-negative breast cancer (TNBC) is defined by a lack of estrogen receptor (ER), pr...
Main Author: | XIAO Yuling, ZHU Xiuzhi, JIANG Yizhou, SHAO Zhimin |
---|---|
Format: | Article |
Language: | English |
Published: |
Editorial Office of China Oncology
2022-08-01
|
Series: | Zhongguo aizheng zazhi |
Subjects: | |
Online Access: | http://www.china-oncology.com/fileup/1007-3639/PDF/1663559391064-707647498.pdf |
Similar Items
-
Precision Medicine and Triple-Negative Breast Cancer: Current Landscape and Future Directions
by: Fokhrul Hossain, et al.
Published: (2021-07-01) -
Recent advances in targeted strategies for triple-negative breast cancer
by: Shuangli Zhu, et al.
Published: (2023-08-01) -
Research Progress on Molecular Subtyping and Modern Treatment of Triple-Negative Breast Cancer
by: Tong L, et al.
Published: (2023-08-01) -
Standard of Care and Promising New Agents for the Treatment of Mesenchymal Triple-Negative Breast Cancer
by: Silvia Mezi, et al.
Published: (2021-03-01) -
Triple negative breast cancer: special histological types and emerging therapeutic methods
by: Lu Cao, et al.
Published: (2020-05-01)